Corrigendum: CXCL17 Is a Specific Diagnostic Biomarker for Severe Pandemic Influenza A(H1N1) That Predicts Poor Clinical Outcome (Frontiers in Immunology, (2021), 12, (633297), 10.3389/fimmu.2021.633297)

Copyright © 2021 Choreño-Parra, Jiménez-Á lvarez, Ram¿¿rez-Mart¿¿nez, Sandoval-Vega, Salinas-Lara, Sánchez-Garibay, Luna-Rivero, Hernández-Montiel, Fernández-López, Cabrera-Cornejo, Choreño-Parra, Cruz-Lagunas, Dom¿¿nguez, Márquez-Garc¿¿a, Cabello-Gutiérrez, Bolaños-Morales, Mena-Hernández, Delgado-Zaldivar, Rebolledo-Garc¿¿a, Guadarrama-Ortiz, Regino-Zamarripa, Mendoza-Milla, Garc¿¿a-Latorre, Rodr¿¿guez-Reyna, Cervántes-Rosete, Hernández-Cárdenas, Khader, Zlotnik and Zúñiga.An author name was incorrectly spelled as Tatiana Sofia Rodiguez-Reyna. The correct spelling is Tatiana Sof¿¿a Rodr¿¿guez-Reyna. In the published article, there was also an error in the affiliation of Criselda Mendoza-Milla. Instead of ¿Laboratorio de Inmunobiolog¿¿a y Genética, Instituto Nacional de Enfermedades Respiratorias ¿Ismael Cos¿¿o Villegas¿, Mexico City, Mexico¿, it should be ¿Departamento de Fibrosis Pulmonar, Instituto Nacional de Enfermedades Respiratorias ¿Ismael Cos¿¿o Villegas¿, Mexico City, Mexico¿. The authors apologize for these errors and state that they do not change the scientific conclusions of the article in any way. The original article has been updated.

Corrigendum: CXCL17 Is a Specific Diagnostic Biomarker for Severe Pandemic Influenza A(H1N1) That Predicts Poor Clinical Outcome (Frontiers in Immunology, (2021), 12, (633297), 10.3389/fimmu.2021.633297) Academic Article in Scopus